These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25805504)

  • 1. Capsule Commentary on Shelton et al., Reducing PSA-Based Prostate Cancer Screening in Men ≥ 75 Years Old with Highly Specific Computerized Clinical Decision Support.
    Slight SP
    J Gen Intern Med; 2015 Aug; 30(8):1187. PubMed ID: 25805504
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing PSA-Based Prostate Cancer Screening in Men Aged 75 Years and Older with the Use of Highly Specific Computerized Clinical Decision Support.
    Shelton JB; Ochotorena L; Bennett C; Shekelle P; Kwan L; Skolarus T; Goldzweig C
    J Gen Intern Med; 2015 Aug; 30(8):1133-9. PubMed ID: 25740462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 4. Overuse of PSA testing in healthy men.
    Angelsen A
    Tidsskr Nor Laegeforen; 2013 Sep; 133(16):1678. PubMed ID: 24005680
    [No Abstract]   [Full Text] [Related]  

  • 5. [Re: PSA measurement and prostate cancer--overdiagnosis and overtreatment?].
    Øverbye BJ
    Tidsskr Nor Laegeforen; 2014 May; 134(10):1024. PubMed ID: 24865722
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer: measuring PSA.
    Pezaro C; Woo HH; Davis ID
    Intern Med J; 2014 May; 44(5):433-40. PubMed ID: 24816306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [No significant effect of PSA screening].
    Zahl PH
    Tidsskr Nor Laegeforen; 2013 Oct; 133(20):2120. PubMed ID: 24172615
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
    Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. States renewing attention to prostate cancer.
    Rossiter C
    NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited commentary: Prostate cancer: doing less might be more. Comment on "Severity of comorbidity and non-prostate cancer mortality in men with early-stage prostate cancer".
    Ablin RJ; Sartor O; Bennett CL
    Arch Intern Med; 2010 Aug; 170(15):1397-9. PubMed ID: 20696969
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate-specific antigen-based prostate cancer screening: Past and future.
    Alberts AR; Schoots IG; Roobol MJ
    Int J Urol; 2015 Jun; 22(6):524-32. PubMed ID: 25847604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of prostate cancer. Role of prostate-specific antigen.
    Prabhakaran VM
    Can Fam Physician; 1996 Apr; 42():709-12. PubMed ID: 8653039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.
    Carter HB; Epstein JI; Chan DW; Fozard JL; Pearson JD
    JAMA; 1997 May; 277(18):1456-60. PubMed ID: 9145718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer Screening and the Associated Controversy.
    Tabayoyong W; Abouassaly R
    Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer: prostate-specific antigen testing is not effective.
    Hitzeman N; Molina M
    Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence does not support routine PSA testing, say experts.
    McCarthy M
    BMJ; 2013 May; 346():f2982. PubMed ID: 23661116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
    Kato M; Okada K
    Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Re: Implementation of guidelines for PSA testing in general practice].
    Eri LM
    Tidsskr Nor Laegeforen; 2015 Jan; 135(1):15. PubMed ID: 25589118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.